Elbit Imaging Ltd. Announces That INSIGHTEC’s Exablate Neuro System Has Been Approved by CMS for U.S. Coverage for the Treatment of Essential Tremor

EconoTimes – Elbit Imaging Ltd. announced today that it was informed by INSIGHTEC Ltd. that the Centers for Medicare and Medicaid Services assigned a status to the Exablate Neuro treatment for Essential Tremor, moving it from a non-payable status indicator to one that allows reimbursement. The CMS decision is one of several steps toward gaining appropriate reimbursement for MRgFUS for essential tremor. This needs to be followed by CMS regional offices approval to the reimbursement for the Exablate Neuro treatment, for their patients.